Graminex®, L.L.C.完成关注女性尿失禁问题的Graminex® Flower Pollen Extract临床试验,并获得积极结果

2022-08-03 网络 网络

初步分析表明,Graminex® Flower Pollen Extract研究小组在多项尿失禁生活质量指标方面出现明显改善。

Graminex®, L.L.C.欣然宣布,已针对女性尿失禁和泌尿系统健康完成了Graminex® Flower Pollen Extract临床研究,并获得积极结果。这项随机、双盲、安慰剂对照研究旨在调查Graminex® Flower Pollen Extract对190名尿失禁女性患者的有效性。初步分析表明,Graminex® Flower Pollen Extract研究小组在多项尿失禁生活质量指标方面出现明显改善。

多年来,业界一直在研究花粉提取物对女性更年期症状的效用。最近,Graminex®在女性健康的一个细分类别——尿失禁,特别是压力引起的急迫性尿失禁方面发现了花粉提取物的益处。尿失禁在产后女性以及更年期女性中更为突出。

首席商务官Colleen May表示:“大量妇女因尿失禁而导致生活质量下降。在这些研究结果的支持下,Graminex很高兴能提供一种天然替代产品,在最需要的时候改善女性的生活质量。”

关于Graminex® L.L.C.

Graminex® L.L.C.是天然及无溶剂Graminex® Flower Pollen Extract™的领先生产商。Graminex®在俄亥俄州西北部直接拥有和经营超过6,500英亩农场,以满足其客户的需求。Graminex种植、加工Graminex的活性成分,用于膳食补剂、营养品、药品、食品、皮肤护理行业。Graminex®营销其自有的膳食补剂产品线,侧重于前列腺健康、尿路健康、维护更年期健康和皮肤护理。

评论区 (5)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1657664, encodeId=8bdd165e6642c, content=<a href='/topic/show?id=3ca31e71903' target=_blank style='color:#2F92EE;'>#TRA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=116, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=17719, encryptionId=3ca31e71903, topicName=TRA)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=757b24868428, createdName=bsmagic9140, createdTime=Sun Sep 18 17:13:51 CST 2022, time=2022-09-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1763235, encodeId=fa901e632354c, content=<a href='/topic/show?id=b2591e7241b' target=_blank style='color:#2F92EE;'>#Tract#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=111, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=17724, encryptionId=b2591e7241b, topicName=Tract)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4b2037445014, createdName=12498877m110暂无昵称, createdTime=Wed Apr 12 15:13:51 CST 2023, time=2023-04-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1785937, encodeId=51981e85937e6, content=<a href='/topic/show?id=b8c0e17672' target=_blank style='color:#2F92EE;'>#extract#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=103, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=7176, encryptionId=b8c0e17672, topicName=extract)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=87f580, createdName=yilong5287542, createdTime=Thu Jun 22 16:13:51 CST 2023, time=2023-06-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1281696, encodeId=4cb41281696ee, content=<a href='/topic/show?id=0c3c4e407ec' target=_blank style='color:#2F92EE;'>#尿失禁#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=139, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=47407, encryptionId=0c3c4e407ec, topicName=尿失禁)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=872f168, createdName=gracezdd, createdTime=Thu Aug 04 04:13:51 CST 2022, time=2022-08-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1619136, encodeId=09fa16191360a, content=<a href='/topic/show?id=746244636ee' target=_blank style='color:#2F92EE;'>#女性尿失禁#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=113, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=44636, encryptionId=746244636ee, topicName=女性尿失禁)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a12645, createdName=docwu2019, createdTime=Thu Aug 04 04:13:51 CST 2022, time=2022-08-04, status=1, ipAttribution=)]
    2022-09-18 bsmagic9140

    #TRA#

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=1657664, encodeId=8bdd165e6642c, content=<a href='/topic/show?id=3ca31e71903' target=_blank style='color:#2F92EE;'>#TRA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=116, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=17719, encryptionId=3ca31e71903, topicName=TRA)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=757b24868428, createdName=bsmagic9140, createdTime=Sun Sep 18 17:13:51 CST 2022, time=2022-09-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1763235, encodeId=fa901e632354c, content=<a href='/topic/show?id=b2591e7241b' target=_blank style='color:#2F92EE;'>#Tract#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=111, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=17724, encryptionId=b2591e7241b, topicName=Tract)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4b2037445014, createdName=12498877m110暂无昵称, createdTime=Wed Apr 12 15:13:51 CST 2023, time=2023-04-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1785937, encodeId=51981e85937e6, content=<a href='/topic/show?id=b8c0e17672' target=_blank style='color:#2F92EE;'>#extract#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=103, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=7176, encryptionId=b8c0e17672, topicName=extract)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=87f580, createdName=yilong5287542, createdTime=Thu Jun 22 16:13:51 CST 2023, time=2023-06-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1281696, encodeId=4cb41281696ee, content=<a href='/topic/show?id=0c3c4e407ec' target=_blank style='color:#2F92EE;'>#尿失禁#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=139, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=47407, encryptionId=0c3c4e407ec, topicName=尿失禁)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=872f168, createdName=gracezdd, createdTime=Thu Aug 04 04:13:51 CST 2022, time=2022-08-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1619136, encodeId=09fa16191360a, content=<a href='/topic/show?id=746244636ee' target=_blank style='color:#2F92EE;'>#女性尿失禁#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=113, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=44636, encryptionId=746244636ee, topicName=女性尿失禁)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a12645, createdName=docwu2019, createdTime=Thu Aug 04 04:13:51 CST 2022, time=2022-08-04, status=1, ipAttribution=)]
  3. [GetPortalCommentsPageByObjectIdResponse(id=1657664, encodeId=8bdd165e6642c, content=<a href='/topic/show?id=3ca31e71903' target=_blank style='color:#2F92EE;'>#TRA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=116, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=17719, encryptionId=3ca31e71903, topicName=TRA)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=757b24868428, createdName=bsmagic9140, createdTime=Sun Sep 18 17:13:51 CST 2022, time=2022-09-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1763235, encodeId=fa901e632354c, content=<a href='/topic/show?id=b2591e7241b' target=_blank style='color:#2F92EE;'>#Tract#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=111, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=17724, encryptionId=b2591e7241b, topicName=Tract)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4b2037445014, createdName=12498877m110暂无昵称, createdTime=Wed Apr 12 15:13:51 CST 2023, time=2023-04-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1785937, encodeId=51981e85937e6, content=<a href='/topic/show?id=b8c0e17672' target=_blank style='color:#2F92EE;'>#extract#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=103, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=7176, encryptionId=b8c0e17672, topicName=extract)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=87f580, createdName=yilong5287542, createdTime=Thu Jun 22 16:13:51 CST 2023, time=2023-06-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1281696, encodeId=4cb41281696ee, content=<a href='/topic/show?id=0c3c4e407ec' target=_blank style='color:#2F92EE;'>#尿失禁#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=139, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=47407, encryptionId=0c3c4e407ec, topicName=尿失禁)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=872f168, createdName=gracezdd, createdTime=Thu Aug 04 04:13:51 CST 2022, time=2022-08-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1619136, encodeId=09fa16191360a, content=<a href='/topic/show?id=746244636ee' target=_blank style='color:#2F92EE;'>#女性尿失禁#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=113, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=44636, encryptionId=746244636ee, topicName=女性尿失禁)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a12645, createdName=docwu2019, createdTime=Thu Aug 04 04:13:51 CST 2022, time=2022-08-04, status=1, ipAttribution=)]
    2023-06-22 yilong5287542

    #extract#

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=1657664, encodeId=8bdd165e6642c, content=<a href='/topic/show?id=3ca31e71903' target=_blank style='color:#2F92EE;'>#TRA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=116, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=17719, encryptionId=3ca31e71903, topicName=TRA)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=757b24868428, createdName=bsmagic9140, createdTime=Sun Sep 18 17:13:51 CST 2022, time=2022-09-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1763235, encodeId=fa901e632354c, content=<a href='/topic/show?id=b2591e7241b' target=_blank style='color:#2F92EE;'>#Tract#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=111, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=17724, encryptionId=b2591e7241b, topicName=Tract)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4b2037445014, createdName=12498877m110暂无昵称, createdTime=Wed Apr 12 15:13:51 CST 2023, time=2023-04-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1785937, encodeId=51981e85937e6, content=<a href='/topic/show?id=b8c0e17672' target=_blank style='color:#2F92EE;'>#extract#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=103, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=7176, encryptionId=b8c0e17672, topicName=extract)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=87f580, createdName=yilong5287542, createdTime=Thu Jun 22 16:13:51 CST 2023, time=2023-06-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1281696, encodeId=4cb41281696ee, content=<a href='/topic/show?id=0c3c4e407ec' target=_blank style='color:#2F92EE;'>#尿失禁#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=139, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=47407, encryptionId=0c3c4e407ec, topicName=尿失禁)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=872f168, createdName=gracezdd, createdTime=Thu Aug 04 04:13:51 CST 2022, time=2022-08-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1619136, encodeId=09fa16191360a, content=<a href='/topic/show?id=746244636ee' target=_blank style='color:#2F92EE;'>#女性尿失禁#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=113, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=44636, encryptionId=746244636ee, topicName=女性尿失禁)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a12645, createdName=docwu2019, createdTime=Thu Aug 04 04:13:51 CST 2022, time=2022-08-04, status=1, ipAttribution=)]
    2022-08-04 gracezdd
  5. [GetPortalCommentsPageByObjectIdResponse(id=1657664, encodeId=8bdd165e6642c, content=<a href='/topic/show?id=3ca31e71903' target=_blank style='color:#2F92EE;'>#TRA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=116, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=17719, encryptionId=3ca31e71903, topicName=TRA)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=757b24868428, createdName=bsmagic9140, createdTime=Sun Sep 18 17:13:51 CST 2022, time=2022-09-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1763235, encodeId=fa901e632354c, content=<a href='/topic/show?id=b2591e7241b' target=_blank style='color:#2F92EE;'>#Tract#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=111, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=17724, encryptionId=b2591e7241b, topicName=Tract)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4b2037445014, createdName=12498877m110暂无昵称, createdTime=Wed Apr 12 15:13:51 CST 2023, time=2023-04-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1785937, encodeId=51981e85937e6, content=<a href='/topic/show?id=b8c0e17672' target=_blank style='color:#2F92EE;'>#extract#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=103, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=7176, encryptionId=b8c0e17672, topicName=extract)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=87f580, createdName=yilong5287542, createdTime=Thu Jun 22 16:13:51 CST 2023, time=2023-06-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1281696, encodeId=4cb41281696ee, content=<a href='/topic/show?id=0c3c4e407ec' target=_blank style='color:#2F92EE;'>#尿失禁#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=139, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=47407, encryptionId=0c3c4e407ec, topicName=尿失禁)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=872f168, createdName=gracezdd, createdTime=Thu Aug 04 04:13:51 CST 2022, time=2022-08-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1619136, encodeId=09fa16191360a, content=<a href='/topic/show?id=746244636ee' target=_blank style='color:#2F92EE;'>#女性尿失禁#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=113, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=44636, encryptionId=746244636ee, topicName=女性尿失禁)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a12645, createdName=docwu2019, createdTime=Thu Aug 04 04:13:51 CST 2022, time=2022-08-04, status=1, ipAttribution=)]
    2022-08-04 docwu2019

相关资讯

J Urol:根治性前列腺切除术后新发储尿功能障碍是否常见?

评估了男性新发储尿功能障碍的流行率、自然史和风险因素。

BJU Int:根治性前列腺切除术后,哪些患者需要进行尿失禁手术干预?

调查了前列腺根治术后患者报告的尿失禁和困扰评分是否会导致随后的尿失禁手术干预。

EU :腹腔镜 VS 机器人 哪种方式进行根治性前列腺切除术更好?

根治性前列腺切除术(RP)后尿失禁深深地影响患者生活质量。机器人辅助根治性前列腺切除术(RARP)和腹腔镜RP (LRP)是常用的手术方式,研究显示它们对肿瘤治疗效果无差异,而前者对控尿更好。

Radiology:这一前列腺MRI测量值,可实现对前列腺切除术后尿失禁的无创预测!

根治性前列腺切除术(RP)后的尿失禁是决定患者生活质量的一个重要因素。在一项荟萃分析中,RP术后1年的尿失禁发生率为4%至31%。

Eur Urol Focus:人工尿道括约肌治疗术后应激性尿失禁的效果如何?

比较了PPI患者植入AUS后的尿失禁结果与BPO手术后植入AUS的尿失禁结果。

BMJ Support Palliat Care:电针治疗可有效改善老年女性的压力性尿失禁

EA可能是治疗老年和非老年妇女SUI或压力为主的MUI的有效和安全的替代疗法。年龄可能不会影响电针的治疗效果。

拓展阅读

Nat Med:Ubrogepant治疗偏头痛前驱症状的探索性分析

该研究揭示了ubrogepant在偏头痛前驱期的应用能够显著缓解如光敏感、疲劳等常见前驱症状,并降低头痛发作的风险,阐明了CGRP受体拮抗剂在偏头痛早期干预中的潜在价值和临床意义。

专家论坛|孔媛媛:白蛋白临床试验设计中的统计学考量

本文将主要从统计学角度探讨白蛋白注册临床试验设计中的若干关键问题,包括主要终点的选择、统计学假设、非劣效界值、样本量计算以及腹水改善标准的确定等,以期为白蛋白临床试验设计提供参考。

乙肝治疗性疫苗:从实验室到临床,治愈之路还有多远?

疫苗对疾病防控意义重大,乙肝治疗性疫苗应运而生。文章介绍其设计原理,梳理国内外临床试验品种及在研疫苗,指出虽有进展但总体疗效欠佳,亟待理论与方法创新。

Phytomedicine:桂枝茯苓胶囊可通过降低白细胞介素-6水平调节mTOR通路诱导的自噬来缓解硼替佐米所致的周围神经病变

该研究探讨桂枝茯苓胶囊(GZFL)治疗硼替佐米诱导的周围神经病变(BiPN)的疗效及机制。

Nat Med:2025年影响医学发展的11项临床试验

2024 年的大赢家是重磅减肥药索马鲁肽(诺和诺德的 Wegovy)和替泽帕肽(礼来公司的 Zepbound)背后的制药公司。随着其他生物技术和制药公司纷纷进入减肥市场,肥胖症必将成为 2025 年的

社区老年患者尿失禁居家康复管理中国专家共识(2025版)

中国康复医学会(Chinese Association Of Rehabilitation Medicine) · 2025-05-22

2024 AUA/GURS/SUFU指南:前列腺治疗后尿失禁(更新版)

美国泌尿外科学会(AUA,American Urological Association) · 2024-06-27

老年尿失禁护理专家共识

暂未更新 · 2022-10-01